EUVIMEDEUVIMED entdecken
Crossref

Myeloid‐derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure

Nabil Subhi-Issa Marin iD, Eduardo de la Fuente-Muñoz, Raquel Gil-Laborda, Ángela Villegas, Bárbara Alonso-Arenilla, Ignacio Cristóbal, Lydia Pilar-Suárez, Adolfo Jiménez-Huete, Marta Calvo, Beatriz Sarria, Mariló Mansilla-Ruiz, Juliana Ochoa und 2 weitere

American Journal of Reproductive Immunology · 2023

DOI: 10.1111/aji.13783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2023. Verfasst von Nabil Subhi-Issa Marin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Abortion, Habitual. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem Recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) represent distinct clinical conditions with established definitions, both of which have been linked to an underlying pro‐inflammatory state. This study aimed to explore the levels of monocytic‐myeloid‐derived suppressor cells (M‐MDSCs) and regulatory T cells (T Reg ) in a cohort of RPL and RIF women and their potential contribution to RPL and RIF. Method of study One hundred and eight non‐pregnant women were evaluated: 40 RPL, 41 RIF, and 27 fertile healthy controls (HC). A multiparametric flow cytometry approach was utilized to measure and quantify the frequency of M‐MDSCs and T Reg cells. Cytokine levels in plasma samples were evaluated through a multiplex assay. M‐MDSCs levels were significantly higher in RPL and RIF patients compared to HC.

Results

M‐MDSCs levels were significantly higher in RPL (9.4% [7–11.6]) and RIF (8.1% [5.9–11.6]) patients compared to HC (6% [4.2–7.6]). An optimal cut‐off of 6.1% for M‐MDSCs disclosed a sensitivity of 75.6% and 89.7% and a specificity of 57.7% and 57.7% in RIF and RPL groups, respectively. A significant negative correlation was observed between M‐MDSCs and T Reg ( p = .002, r = −.51).

Conclusions

Our preliminary data allowed us to build a predictive model that may aid as a potential diagnostic tool in the clinic. These findings could provide a better understanding of these pathologies and a better definition of patients that could benefit from personalized treatments to promote pregnancy. Additional exploration and confirmation in distinct study groups are needed to fully assess the diagnostic capabilities of this biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsAbortion, HabitualPregnancyHumansFemaleT-Lymphocytes, RegulatoryFertilityBiomarkers

Stichwörter der Autor:innen

MDSCsinflammationmyeloid-derived suppressor cellsrecurrent implantation failurerecurrent pregnancy lossregulatory T cells

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Immunology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
  • Department of Immunology, Ophthalmology, and ENT, School of Medicine, Complutense University School of Medicine, Madrid, Spain.
  • Department of Obstetrics and Gynecology, Hospital Clínico San Carlos, Madrid, Spain.
  • Department of Neurology, Clínica Universidad Navarra, Madrid, Spain.
  • Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), Madrid, Spain.

ORCID-Profile: Nabil Subhi-Issa Marin

Zitieren

APA

Marin, N. S., Fuente-Muñoz, E., Gil-Laborda, R., Villegas, Á., Alonso-Arenilla, B., Cristóbal, I., Pilar-Suárez, L., Jiménez-Huete, A., Calvo, M., Sarria, B., Mansilla-Ruiz, M., Ochoa, J., Fernández-Arquero, M., & Sánchez-Ramón, S. (2023). Myeloid‐derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13783

Vancouver

Marin NS, Fuente-Muñoz E, Gil-Laborda R, Villegas Á, Alonso-Arenilla B, Cristóbal I, et al. Myeloid‐derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure. American Journal of Reproductive Immunology. 2023. doi:10.1111/aji.13783

BibTeX
@article{Marin2023,
  author = {Marin, Nabil Subhi-Issa and Fuente-Muñoz, Eduardo de la and Gil-Laborda, Raquel and Villegas, Ángela and Alonso-Arenilla, Bárbara and Cristóbal, Ignacio and Pilar-Suárez, Lydia and Jiménez-Huete, Adolfo and Calvo, Marta and Sarria, Beatriz and Mansilla-Ruiz, Mariló and Ochoa, Juliana and Fernández-Arquero, Miguel and Sánchez-Ramón, Silvia},
  title = {Myeloid‐derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure},
  journal = {American Journal of Reproductive Immunology},
  year = {2023},
  doi = {10.1111/aji.13783}
}
Kostenlos starten →